Searchable abstracts of presentations at key conferences in endocrinology

ea0070aep995 | Thyroid | ECE2020

Performance of a dual-component molecular assay in cytologically indeterminate thyroid nodules

Sponziello Marialuisa , Verrienti Antonella , Pecce Valeria , Abballe Luana , Grani Giorgio , Ramundo Valeria , Fadda Guido , Brunelli Chiara , Durante Cosimo , Filetti Sebastiano

Background: Deciding whether patients with a cytologically indeterminate thyroid nodule should be referred for surgery or for active surveillance is an important challenge for clinicians. The aim of this study was to evaluate the performance of a novel dual-component molecular assay as an ancillary molecular method for resolving indeterminate thyroid nodule cytology.Methods: We selected 156 thyroid nodules from those that had undergone both FNA cytology ...

ea0032p991 | Thyroid (non-cancer) | ECE2013

Quantification of tissue T3 and T4 in rat and human heart by a novel HPLC-MS/MS method

Saba Alessandro , Colligiani Daria , Nannipieri Monica , Kusmic Claudia , Dos Remedios Cristobal , Simonides Warner , Iervasi Giorgio , Zucchi Riccardo

Thyroid hormone (T3) is mostly produced in peripheral tissues by thyroxine (T4) deiodination, and its functional effects are directly related to tissue concentration, which is quite difficult to assay by conventional immunological methods. We report a novel technique, based on tandem mass spectrometry (MS/MS) coupled to HPLC, which was used in left ventricular myocardium obtained from rat and human hearts.Samples were homogenized in...

ea0026p710 | Diabetes (epidemiology, pathophysiology) | ECE2011

Continuous glucose monitoring enhances the diagnostic value of mixed meal test in reactive hypoglycemia

Olivetti Ilaria , Grassi Giorgio , Lambertenghi Veronica , Tomelini Michela , Gigliardi Valentina Ramella , Gramaglia Elena , Ghigo Ezio , Broglio Fabio

Background: Clinical reactive hypoglycemic events are defined as the coexistence of plasma glucose <60 mg/dl and autonomic and/or neuroglycopenic symptoms occurring in fed conditions. The diagnosis is based on tests aiming to simulate the causative triggers (i.e. mixed meal test). In clinical practice, however, a high percentage of symptomatic patients results negative to such diagnostic approach, leading to the impression of an inadequate sensitivity of this diagnostic to...

ea0022oc2.3 | Thyroid | ECE2010

Allelic discrimination in the diagnosis of somatic BRAF V600E mutation on fine-needle aspiration biopsies

Buratto Mattia , Tagliati Federico , Trasforini Giorgio , Leoni Stefania , Rossi Roberta , degli Uberti Ettore C , Zatelli Maria Chiara

Many studies demonstrated that somatic BRAF gene mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma (PTC), even from very small samples. The gold standard for point mutations research is direct sequencing, that implies DNA extraction, PCR with specific primers, sequencing reaction and run on an automatic sequencer. This is an expensive and time consuming method, and the possible contamination with wild-type DNA not coming from the nodule significan...

ea0022p605 | Neuroendocrinology and Pituitary (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

The regulation of the hypothalamic-pituitary axis is altered in transgenic male mice overexpressing human chorionic gonadotrophin (hCG)

Gonzalez Betina , Di Giorgio Noelia , Ratner Laura , Poutanen Matti , Huhtaniemi Ilpo , Calandra Ricardo , Lux-Lantos Victoria , Rulli Susana

Male transgenic (TG) mice overexpressing both the hCGα- and hCGβ- subunits present elevated levels of circulating hCG, Leydig cell hyperplasia/hypertrophy, elevated androgen levels and infertility (Rulli et al. 2003). In addition, serum FSH is significantly reduced in prepuberal and adult TG males compared with wild-types (WT), and does not change after treatment with the antiandrogen flutamide. The aim of this study was to evaluate the regulation of the hypot...

ea0022p789 | Thyroid | ECE2010

BRAFV600E analysis on fine needle aspiration biopsy increases diagnostic accuracy for papillary thyroid cancer in clinically unsuspected nodules

Rossi Martina , Trasforini Giorgio , Leoni Stefania , Tagliati Federico , Rossi Roberta , Roti Elio , degli Uberti Ettore C , Zatelli Maria Chiara

Papillary thyroid cancer (PTC) represents the majority of differentiated thyroid cancers, presenting in 29–83% of cases the activating BRAF V600E mutation. The aim of our study was to analyse the influence of BRAF V600E mutation analysis on diagnostic accuracy of fine needle aspiration biopsies (FNAB) in clinically unsuspected thyroid nodules. We therefore enrolled 496 patients (383 females, 113 males; mean age 52 years), for a total of 671 samples. FNAB were evaluated by...

ea0056p1032 | Thyroid (non-cancer) | ECE2018

Thyroid disease in PHPT: a single centre study

Castellano Elena , Gianotti Laura , Latina Adele , Cesario Flora , Baffoni Claudia , Pellegrino Micaela , Tassone Francesco , Magro Giampaolo , Borretta Giorgio

Objective: Primary hyperparathyroidism (PHPT) and thyroid diseases are common in the general population. It is difficult to establish whether they occur in the same patient because of a direct relationship or just due to the widespread prevalence of both conditions. The reported prevalence of the concomitant occurrence of these two clinical conditions is widely scattered (ranging 17–84%), especially due to the heterogeneous criteria for patient selection. We aimed to eval...

ea0073pep8.5 | Presented ePosters 8: Pituitary and Neuroendocrinology | ECE2021

Osilodrostat provides sustained control of urinary free cortisol in patients with Cushing’s disease: final results from a prospective, open-label study (LINC 2)

Fleseriu Maria , Biller Beverly , Bertherat Jerome , Young Jacques , Arnaldi Giorgio , O’Connell Paul , Izquierdo Miguel , Pedroncelli Alberto , Pivonello Rosario

IntroductionThe oral 11β-hydroxylase inhibitor, osilodrostat, normalized mean urinary free cortisol (mUFC) in 79% (15/19) of patients with Cushing’s disease at the end of the 22-week core LINC 2 study. Long-term efficacy and safety data following an optional extension phase are reported here.MethodsPatients with clinical benefit at week 22 could continue receiving osilodrostat during the extension; ...

ea0081rc5.8 | Rapid Communications 5: Diabetes, Obesity, Metabolism and Nutrition 2 | ECE2022

Attitude of Italian endocrinologists towards obesity management. Results of a survey with 534 respondents

Chianelli Marco , Eugenia Disoteo Olga , Giorgio Borretta , Attanasio Roberto , Persichetti Agnese , GRIMALDI FRANCO , Paoletta Agostino , Samperi Irene , Papini Enrico , Guglielmi Rinaldo , Scoppola Alessandro

Background: Obesity represents a threatening worldwide epidemic but, beyond the guidelines recommendations, its modalities of treatment in the medical community appear as variable and not clearly defined. Aim of our survey was to assess the present real-world approach to obesity management in Italy.Methods: Online anonymous survey among the 2248 members of the Italian Association of Clinical Endocrinologists (AME). The survey included 8 questions about d...

ea0081rc13.3 | Rapid Communications 13: Adrenal and Cardiovascular Endocrinology 2 | ECE2022

Steroidomic approach for the characterization of patients with non-alcoholic fatty liver disease

Parasiliti Caprino Mirko , Rosso Chiara , Ponzetto Federico , Paolo Caviglia Gian , Lopez Chiara , Armandi Angelo , Maria Saracco Giorgio , Ghigo Ezio , Bugianesi Elisabetta , Maccario Mauro

Introduction: The onset and progression of liver damage in non-alcoholic fatty liver disease (NAFLD) is tightly associated with metabolic derangements. Steroids may affect lipid metabolism but their alterations in the setting of NAFLD remain to be fully explored.Patients and Methods: We analyzed data from 121 patients with biopsy-proven NAFLD and 108 controls (CT). A panel of 26 steroids (including glucocorticoids, mineralocorticoids, androgens, and prog...